Marcus Nikos
Stop Fighting Your Nature
My Short on RILY bought my Holding Company this Villa. How did you make out on the RILY Trade? If you want new ideas, read old books. **...
top of page
.png){kind=small}
RESEARCH
Executive Investment Research for All Investors…
Discover the most disruptive Investments in the Market,Bio-Tech, FDA Approvals, Drug Misses, Takeovers, Earnings Surprises, the List goes on and on, Option trading both short-term and Huge Profit long-term trades. Professional Commodity and FOREX Future trading all in Actionable easy to Undersand Trade setups from the Infamous Wall Street 10. Begin your journey as an Insider today with the Best Information on Wall Street…
LATEST ARTICLES
Read the latest insights from the world of high Level Thinkers.
About Marcus Wolff Nikos Research
Marcus Wolf Nikos Research. We set the Standard for High Level Market Research. is a boutique investment research firm that consistently delivers insights and profitable investment recommendations to its subscribers.
For too long, the best investment research has not been available to individual investors. It has been typically reserved for investment banks, hedge funds, private equity, and high-net-worth clients.
The mission of Verum Standard Research is to make that kind of proprietary research available to any investors looking to gain an edge in the markets. The goal is simple… to deliver unique and profitable investment research found nowhere else.
Verum Standard Research publishes one of the most widely read Bio technology e-letters in the world, The Bio-Tech Network , which delivers daily insights and information from the Bio -tech world as well as topics and trends relevant to investments.
.png){kind=small}
RESEARCH
Verum Standard flagship investment newsletter,
The Vision Report, is focused on large-capitalization Bio technology companies that are still in growth mode and deliver outsized returns. Its model portfolio consistently outperforms the markets year after year.
Additionally, Verum Standard Research publishes highly specialized, alpha-driven investment research in The Compound Effect , Early Stage Trader,Blank Check Mastery , Outlier Investor, and Renaissance Profits. Nikos Unlimited focuses on small- and micro-capitalization Bio technology companies on the Vision Report whereas Early Stage Trader focuses primarily on early stage, pre-revenue biotechnology companies developing novel approaches to curing human disease. Blank Check Mastery specializes in finding the most exciting investments from the world of special purpose acquisition corporations (SPACs).
.png){kind=small}
RESEARCH
RESEARCH
.png){kind=small}
RESEARCH
bottom of page